Navigation Links
Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:9/21/2007

s to Subjects with Severe Renal Impairment"

Cethromycin at 300 mg QD for five days was well tolerated by both subjects with severe renal impairment and with normal renal function. Elevated drug exposure observed for subjects with severe renal impairment suggest that these patients should be monitored when taking cethromycin.

The following poster presentations discussed cethromycin as a potential treatment for CAP, particularly when resistance to other treatments is known:

"Assessment of In Vitro Activity of Cethromycin Against Telithromycin-resistant Strains of Streptococcus Pneumoniae"

All eight clinical Streptococcus pneumoniae isolates were resistant to erythromycin with MICs > 128 micron g/mL and had telithromycin MICs >/= 2 micron g/mL. For six of these isolates, the cethromycin MIC was at least 8-fold lower than the telithromycin MIC, for another isolate the MICs were the same, and for the other the telithromycin MIC was one doubling dilution lower than the cethromycin MIC.

Cethromycin maintained good in vitro potency against a collection of telithromycin-resistant S. pneumoniae isolates. This finding suggests that underlying resistance mechanisms that result in reduced telithromycin susceptibility do not affect cethromycin to the same extent. Therefore, cethromycin continues to represent a reasonable potential therapeutic option for S. pneumoniae of this phenotype.

"Assessment of In Vitro Activity of Cethromycin Against Strains of Streptococcus Pneumoniae"

Cethromycin demonstrated potent in vitro activity against all Streptococcus pneumoniae populations studied, regardless of their resistance phenotype. Based on MIC90 data collected, cethromycin was 2-4 times more potent than telithromycin and 10-12 times more potent than the macrolides studied. These findings demonstrate that cethromycin has the potential to be a potent therapeutic option for the treatment of CAP, even for infections caused by strains resistant to cu
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
3. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
7. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
8. Managing Preanalytical Processes for Patient Safety
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
11. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Research explores data ... research also   to   be presented ... ), the global specialty biopharmaceutical company, announces that it ... the American Psychiatric Association (APA) 166th Annual Meeting in ... data being presented represent Shire,s ongoing commitment to the ...
(Date:5/17/2013)... MIAMI LAKES, Fla. , May 17, 2013 ... products and delivery technology company that is developing new, patent-pending ... and minerals, announced today that it will hold a business ... on Wednesday, May 22 nd , 2013 at 4:30 PM ... Brian Tuffin will host the call and will ...
(Date:5/17/2013)... , May 17, 2013 ... developer of oral drug delivery systems, announced today that ... cleared the Company,s Investigational New Drug application(IND) for ORMD-0801, ... pleased to have the FDA clearance to proceed," stated ... "The upcoming trial is a major milestone for Oramed ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... Aug. 19 Perrigo Company (Nasdaq: PRGO;TASE) announced its ... for its Abbreviated New Drug Application (ANDA) for clobetasol ... owner. On August 17, 2010, Galderma filed ... Court for the Northern District of Texas to prevent ...
... 19 Reportlinker.com announces that a new market ... Strategic Analysis of End-user Preferences in ... http://www.reportlinker.com/p0258289/Strategic-Analysis-of-End-user-Preferences-in-the-US-Stem-Cell-Research-Tools-Markets.html The ... brand perceptions of tools and technologies currently at ...
Cached Medicine Technology:Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 3
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... The AMTC team will be screening local ... Convention & Trade Center on June 1st. Professionals and amateurs, ... are free of charge. , Actors, Models and Talent for ... successful artists and grads like Caitlin Kinney - SYTYCD, ... Chris Young - on his Liquid Neon 2013 Tour, Taylor ...
(Date:5/19/2013)... 2013 The legal team at Pulaski ... a concerted effort to connect women and families coping ... drugs Yaz, Yasmin & Ocella with the legal representation ... on the notorious birth control drugs as well as ... , Yaz, Yasmin & Ocella were very popular birth ...
(Date:5/18/2013)... In “Cooking with Spirits for the Spirit: A ... Hall Svisdahl’s new cookbook, readers are transported into the world ... the pickiest eater drool. “I dedicate this book to the ... , Found within the 364 pages of “Cooking with Spirits ... from fast and simple to gourmet. Each recipe greets the ...
(Date:5/18/2013)... 2013) Each year, the American Gastroenterological Association ... and achievements in gastroenterology through its esteemed recognition ... and talented individuals who work tirelessly to advance ... are pleased to announce the 2013 recognition award ... for their tremendous contributions to our field," said ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... , ... The National Institutes of Health (NIH) has awarded a “Grand ... Lencz, PhD, at The Feinstein Institute for Medical Research and Ariel Darvasi, ... the genetic basis of schizophrenia. More than two million dollars was awarded ...
... necessary, safe or effective , FRIDAY, Oct. 9 (HealthDay News) ... kids vaccinated against seasonal influenza or H1N1 swine flu this ... is fighting the flu on her own terms -- ... hands frequently, get plenty of sleep and take their "gummies," ...
... Strong Corporate Values, Employee Engagement and Contributions ... Place to Work, , OTTAWA, Oct. 9 /PRNewswire-FirstCall/ - ... radiopharmaceuticals, has been selected as one of Canada,s Top ... largest publisher of employment-related periodicals and online directories. , ...
... Oct. 9 The outcome of the current healthcare ... need to get healthier. From childhood obesity to alarming ... U.S. have been confronted with the consequences of lives ... the healthcare crisis, it,s that over-emphasizing one part of ...
... Genomma Lab Internacional,S.A.B. de C.V. ("Genomma") (BMV: LAB) announced ... Televisa, S.A.B.,(NYSE: TV ; BMV: TLEVISA CPO), which was ... cosmetics and over-the-counter pharmaceuticals,in the United States and Puerto Rico. ... operations during the first quarter of 2010. , ...
... SINGAPORE, Oct. 9 The global diagnostics industry has ... to Frost & Sullivan, the diagnostics and monitoring sectors ... Nitin Naik, Vice President of Frost & Sullivan,s Asia ... in Asia Pacific are projected to provide more growth ...
Cached Medicine News:Health News:Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia 2Health News:'No Flu Shots for My Kids' 2Health News:'No Flu Shots for My Kids' 3Health News:'No Flu Shots for My Kids' 4Health News:MDS Nordion Selected One of Canada's Top 100 Employers for 2010 2Health News:The Holistic Health Show Offers Relief for Healthcare Crisis 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: